ReviewFrontiers in medicine2024

The Italian breakthrough in CRISPR trials for rare diseases: a focus on beta-thalassemia and sickle cell disease treatment.

Francesca Greco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.